D.A. Clump

1.6k total citations
47 papers, 1.1k citations indexed

About

D.A. Clump is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, D.A. Clump has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Otorhinolaryngology, 24 papers in Pulmonary and Respiratory Medicine and 20 papers in Oncology. Recurrent topics in D.A. Clump's work include Head and Neck Cancer Studies (27 papers), Advanced Radiotherapy Techniques (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). D.A. Clump is often cited by papers focused on Head and Neck Cancer Studies (27 papers), Advanced Radiotherapy Techniques (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). D.A. Clump collaborates with scholars based in United States, Germany and Spain. D.A. Clump's co-authors include Dwight E. Heron, Robert L. Ferris, James Ohr, Julie E. Bauman, William E. Gooding, Steven A. Burton, Sushil Beriwal, Umamaheswar Duvvuri, Barton F. Branstetter and John A. Vargo and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D.A. Clump

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D.A. Clump United States	19	460	413	367	306	208	47	1.1k
N.M. Woody United States	21	251 0.5×	611 1.5×	279 0.8×	382 1.2×	381 1.8×	124	1.3k
K.K. Ang United States	15	580 1.3×	508 1.2×	340 0.9×	390 1.3×	160 0.8×	59	1.4k
Hiroaki Suefuji Japan	20	362 0.8×	346 0.8×	225 0.6×	253 0.8×	189 0.9×	44	946
Yeon‐Sil Kim South Korea	22	546 1.2×	705 1.7×	507 1.4×	454 1.5×	218 1.0×	110	1.6k
Barbara Bachtiary Switzerland	18	216 0.5×	259 0.6×	92 0.3×	242 0.8×	121 0.6×	43	1.0k
Lester Peters Australia	19	368 0.8×	310 0.8×	571 1.6×	497 1.6×	74 0.4×	25	1.2k
Peter M. L. Teo China	14	788 1.7×	490 1.2×	1.2k 3.4×	871 2.8×	99 0.5×	25	1.7k
Lenka Vermeeren Netherlands	20	478 1.0×	361 0.9×	95 0.3×	365 1.2×	90 0.4×	31	1.2k
Harry Yiu China	13	584 1.3×	331 0.8×	716 2.0×	554 1.8×	25 0.1×	16	1.4k
M.S. Kies United States	16	591 1.3×	341 0.8×	296 0.8×	191 0.6×	17 0.1×	49	901

Countries citing papers authored by D.A. Clump

Since Specialization

Citations

This map shows the geographic impact of D.A. Clump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Clump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Clump more than expected).

Fields of papers citing papers by D.A. Clump

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.A. Clump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Clump. The network helps show where D.A. Clump may publish in the future.

Co-authorship network of co-authors of D.A. Clump

This figure shows the co-authorship network connecting the top 25 collaborators of D.A. Clump. A scholar is included among the top collaborators of D.A. Clump based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.A. Clump. D.A. Clump is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lalonde, R.J., et al.. (2023). A novel approach to infectious disease control and radiotherapy risk management. Medical Physics. 50(5). 2683–2694. 2 indexed citations

Zandberg, Dan P., D.A. Clump, Brian R. Isett, et al.. (2023). 856MO A randomized phase II study of concurrent vs. sequential pembrolizumab with chemoradiation (CRT) in locally advanced head and neck cancer (LA HNSCC): 4-year results and tumor-immune microenvironment analysis. Annals of Oncology. 34. S557–S558. 13 indexed citations

Sherman, Eric J., Jonathan Harris, Keith C. Bible, et al.. (2020). 1914MO Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912. Annals of Oncology. 31. S1085–S1085. 4 indexed citations

Reck, Martin, Kathryn F. Mileham, D.A. Clump, et al.. (2020). 1420TiP A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC). Annals of Oncology. 31. S897–S898. 2 indexed citations

Sutera, Philip, Ronny Kalash, D.A. Clump, et al.. (2018). Stereotactic Ablative Radiation Therapy for Unresectable Colorectal Oligometastases. Advances in Radiation Oncology. 4(1). 57–62. 8 indexed citations

Vargo, John A., Vitali Moiseenko, Jimm Grimm, et al.. (2018). Head and Neck Tumor Control Probability: Radiation Dose–Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group. International Journal of Radiation Oncology*Biology*Physics. 110(1). 137–146. 39 indexed citations

Sutera, Philip, D.A. Clump, Ronny Kalash, et al.. (2018). Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 103(1). 116–122. 59 indexed citations

Kansy, Benjamin, Fernando Concha‐Benavente, Raghvendra M. Srivastava, et al.. (2017). PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer. Cancer Research. 77(22). 6353–6364. 174 indexed citations

Horne, Zachary D., et al.. (2017). Stereotactic body radiation therapy for isolated hilar and mediastinal non-small cell lung cancers. Lung Cancer. 115. 1–4. 30 indexed citations

10.

Ling, Diane C., John A. Vargo, Robert L. Ferris, et al.. (2016). Risk of Severe Toxicity Based on Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S67–S67.

11.

Ferris, Robert L., J.L. Geiger, Sumita Trivedi, et al.. (2016). Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer. Annals of Oncology. 27(12). 2257–2262. 21 indexed citations

12.

Xu, Karen M., Yongqian Zhang, D.A. Clump, et al.. (2015). Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma. Seminars in Radiation Oncology. 26(2). 112–119. 11 indexed citations

13.

Clump, D.A., et al.. (2015). Stereotactic Ablative Radiosurgery for Locally Advanced or Recurrent Skull Base Malignancies with Prior External Beam Radiation Therapy. Frontiers in Oncology. 5. 65–65. 6 indexed citations

14.

Xu, Karen M., R.J. Lalonde, Zachary D. Horne, et al.. (2015). Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery. Frontiers in Oncology. 5. 213–213. 19 indexed citations

15.

Vargo, John A., Robert L. Ferris, James Ohr, et al.. (2015). A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 91(3). 480–488. 107 indexed citations

16.

Horne, Zachary D., D.A. Clump, John A. Vargo, et al.. (2014). Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy. Radiation Oncology. 9(1). 41–41. 40 indexed citations

17.

Vargo, John A., Robert L. Ferris, D.A. Clump, & Dwight E. Heron. (2014). Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer. Frontiers in Oncology. 4. 214–214. 31 indexed citations

18.

Leeman, Jonathan E., et al.. (2013). Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases. Neuro-Oncology. 15(12). 1732–1738. 43 indexed citations

19.

Lim, Chwee Ming, D.A. Clump, Dwight E. Heron, & Robert L. Ferris. (2013). Stereotactic Body Radiotherapy (SBRT) for primary and recurrent head and neck tumors. Oral Oncology. 49(5). 401–406. 23 indexed citations

20.

Wang, Kyle, Dwight E. Heron, D.A. Clump, et al.. (2013). Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: A retrospective analysis of the impact of margins and automated PET-CT segmentation. Radiotherapy and Oncology. 106(1). 90–95. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact